General MedicationsINJECTIONGeneric
CIPROFLOXACIN
CIPROFLOXACIN
Standard Dose
200MG/20ML (10MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview CIPROFLOXACIN is listed in Drugs@FDA under application 078062 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CIPROFLOXACIN Form and strength INJECTABLE;INJECTION - 200MG/20ML (10MG/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2019-05-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview CIPROFLOXACIN is listed in Drugs@FDA under application 078062 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CIPROFLOXACIN Form and strength INJECTABLE;INJECTION - 200MG/20ML (10MG/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2019-05-06 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.